Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
Patients with type 2 diabetes mellitus (DM) and those with impaired glucose tolerance are at increased risk for the development of cardiovascular disease. With an increasing global incidence and prevalence of type 2 DM, and with the 2003 lowering of the glucose threshold required for the diagnosis o...
Main Authors: | Bethel, M, Califf, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Treatment of diabetes mellitus: implications of the use of oral agents.
by: Rao, S, et al.
Published: (1999) -
Lifestyle Modification in the Prevention of Type II Diabetes Mellitus
by: Muhammad Umair Khan
Published: (2012-03-01) -
Oral agent therapy in the treatment of type 2 diabetes.
by: Feinglos, M, et al.
Published: (1999) -
EFFICIENCY AND SAFETY OF THE ORAL HYPOGLYCAEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES
by: E. I. Makeeva, et al.
Published: (2016-02-01) -
The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
by: Hala Zakaria, et al.
Published: (2023-02-01)